Cargando…

Examination of Tumor Regression Grading Systems in Breast Cancer Patients Who Received Neoadjuvant Therapy

Neoadjuvant therapy is a common form of treatment in locally advanced breast cancer (LABC) patients. Besides some guidelines for grading regression, a standardized general scheme is not yet available. The aim of our study was to compare the prognostic impact of different regression grading systems,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sejben, Anita, Kószó, Renáta, Kahán, Zsuzsanna, Cserni, Gábor, Zombori, Tamás
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Netherlands 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471177/ https://www.ncbi.nlm.nih.gov/pubmed/32691390 http://dx.doi.org/10.1007/s12253-020-00867-3

Ejemplares similares

Comparison of Nottingham Prognostic Index, PREDICT and PrognosTILs in Triple Negative Breast Cancer –a Retrospective Cohort Study
por: Sejben, Anita, et al.
Publicado: (2020)

Architectural Grade Combined With Spread Through Air Spaces (STAS) Predicts Recurrence and is Suitable for Stratifying Patients Who Might Be Eligible for Lung Sparing Surgery for Stage I Adenocarcinomas
por: Zombori, Tamás, et al.
Publicado: (2020)

Grading Ductal Carcinoma In Situ (DCIS) of the Breast – What’s Wrong with It?
por: Cserni, Gábor, et al.
Publicado: (2019)

Proposal of a grading system for squamous cell carcinoma of the lung — the prognostic importance of tumour budding, single cell invasion, and nuclear diameter
por: Zombori-Tóth, Noémi, et al.
Publicado: (2023)

TRPS1 expression in cytokeratin 5 expressing triple negative breast cancers, its value as a marker of breast origin
por: Almási, Szintia, et al.
Publicado: (2023)

The additional value of ONEST (Observers Needed to Evaluate Subjective Tests) in assessing reproducibility of oestrogen receptor, progesterone receptor, and Ki67 classification in breast cancer
por: Cserni, Bálint, et al.
Publicado: (2021)

The More Extensive the Spread through Air Spaces, the Worse the Prognosis Is: Semi-Quantitative Evaluation of Spread through Air Spaces in Pulmonary Adenocarcinomas
por: Zombori-Tóth, Noémi, et al.
Publicado: (2023)

Individually selected teletherapy technique for accelerated partial breast irradiation
por: Kószó, Renáta L., et al.
Publicado: (2021)

Immunohistochemical Characterization of Reactive Epithelial Changes in Odontogenic Keratocysts
por: Cserni, Dorottya, et al.
Publicado: (2019)

Highlighting the immunohistochemical differences of malignant mesothelioma subtypes via case presentations
por: Sejben, Anita, et al.
Publicado: (2023)

Correlation Between Tumor Regression Grade and Clinicopathological Parameters in Patients With Squamous Cell Carcinoma of the Esophagus Who Received Neoadjuvant Chemoradiotherapy
por: Chao, Yin-Kai, et al.
Publicado: (2015)

A Clinicopathological Approach to Odontogenic Cysts: the Role of Cytokeratin 17 and bcl2 Immunohistochemistry in Identifying Odontogenic Keratocysts
por: Cserni, Dorottya, et al.
Publicado: (2020)

Good practice: The experiences with the utilization of residual cancer burden—A single institution study
por: Sejben, Anita, et al.
Publicado: (2023)

Histological type and typing of breast carcinomas and the WHO classification changes over time
por: Cserni, Gábor
Publicado: (2020)

Predictive role of neostromal CD10 expression in breast cancer patients treated with neoadjuvant chemotherapy
por: Olah, Orsolya, et al.
Publicado: (2023)

Clinical benefit of fulvestrant monotherapy in the multimodal treatment of hormone receptor and HER2 positive advanced breast cancer: a case series
por: Rusz, Orsolya, et al.
Publicado: (2018)

Deep-inspirational breath-hold (DIBH) technique in left-sided breast cancer: various aspects of clinical utility
por: Gaál, Szilvia, et al.
Publicado: (2021)

ONEST (Observers Needed to Evaluate Subjective Tests) Analysis of Stromal Tumour-Infiltrating Lymphocytes (sTILs) in Breast Cancer and Its Limitations
por: Cserni, Bálint, et al.
Publicado: (2023)

Tumor Regression Grading of Gastrointestinal Carcinomas after Neoadjuvant Treatment
por: Thies, Svenja, et al.
Publicado: (2013)

Dose escalation can maximize therapeutic potential of sunitinib in patients with metastatic renal cell carcinoma
por: Maráz, Anikó, et al.
Publicado: (2018)

New tumor regression grade for rectal cancer after neoadjuvant therapy and radical surgery
por: Li, Jun, et al.
Publicado: (2015)

Pathologic Complete Response Rates After Neoadjuvant Pertuzumab and Trastuzumab with Chemotherapy in Early Stage HER2-Positive Breast Cancer - Increasing Rates of Breast Conserving Surgery: A Real-World Experience
por: Boér, Katalin, et al.
Publicado: (2021)

Objective assessment of tumor regression in post-neoadjuvant therapy resections for pancreatic ductal adenocarcinoma: comparison of multiple tumor regression grading systems
por: Matsuda, Yoko, et al.
Publicado: (2020)

Correlation between tumor regression grade and rectal volume in neoadjuvant concurrent chemoradiotherapy for rectal cancer
por: Lee, Hong Seok, et al.
Publicado: (2016)

Comparison of tumor regression grading systems for locally advanced gastric adenocarcinoma after neoadjuvant chemotherapy
por: Liu, Zi-Ning, et al.
Publicado: (2021)

Prognostic significance of tumor regression grade in esophageal squamous cell carcinoma after neoadjuvant chemoradiation
por: Zhang, Chi, et al.
Publicado: (2023)

Multimodal Prediction of Five-Year Breast Cancer Recurrence in Women Who Receive Neoadjuvant Chemotherapy
por: Rabinovici-Cohen, Simona, et al.
Publicado: (2022)

Relevant issues in tumor regression grading of histopathological response to neoadjuvant treatment in adenocarcinomas of the esophagus and gastroesophageal junction
por: Klevebro, F, et al.
Publicado: (2020)

CA724 Predicts Tumor Regression Grade in Locally Advanced Gastric Cancer Patients with Neoadjuvant Chemotherapy
por: Tong, Yilin, et al.
Publicado: (2021)

Prognostic Value of Tumor Regression Grading in Patients Treated With Neoadjuvant Chemotherapy Plus Surgery for Gastric Cancer
por: Xie, Jian-Wei, et al.
Publicado: (2021)

Tumor Lymphocyte Infiltration Is Correlated with a Favorable Tumor Regression Grade after Neoadjuvant Treatment for Esophageal Adenocarcinoma
por: Haddad, Riad, et al.
Publicado: (2022)

The Prognostic Impact of Body Composition for Locally Advanced Breast Cancer Patients Who Received Neoadjuvant Chemotherapy
por: Iwase, Toshiaki, et al.
Publicado: (2021)

Lymph node regression grading of locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy
por: He, Lei, et al.
Publicado: (2022)

Genomic Landscape of Normal and Breast Cancer Tissues in a Hungarian Pilot Cohort
por: Pipek, Orsolya, et al.
Publicado: (2023)

Investigation of the Antihypertrophic and Antifibrotic Effects of Losartan in a Rat Model of Radiation-Induced Heart Disease
por: Kovács, Mónika Gabriella, et al.
Publicado: (2021)

Selective Heart Irradiation Induces Cardiac Overexpression of the Pro-hypertrophic miR-212
por: Sárközy, Márta, et al.
Publicado: (2019)

An observational study to examine changes in metabolic syndrome components in patients with breast cancer receiving neoadjuvant or adjuvant chemotherapy
por: Dieli‐Conwright, Christina M., et al.
Publicado: (2016)

Editorial: Guidelines From the Central-Eastern European Professional Consensus Statement on Breast Cancer
por: Kulka, Janina, et al.
Publicado: (2022)

Tumor regression grade combined with lymph node status in esophageal squamous cell carcinoma after neoadjuvant chemoradiotherapy
por: Yun, Jae Kwang, et al.
Publicado: (2022)

Development of a method for digital assessment of tumor regression grade in patients with rectal cancer following neoadjuvant therapy
por: Jepsen, Dea Natalie Munch, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qsmd2gsms2dg6u9bu5cea84pg8